Products
Clinical Settings
- Blood BanksIn a blood bank, protecting the donor and making the donation process as smooth and safe as possible is crucial. By using a point-of-care hemoglobin test, you can meet the changing needs while protecting the source.
- Public HealthBy providing access to accurate screening tools ideal for use even in field-settings, we help public health workers protect the children shaping our future.
- Hospital CareIn a hospital setting, time is of the essence. Whether detecting internal bleeding in a busy emergency department or monitoring a patient in the intensive care unit, you can benefit from access to immediate, lab-accurate results at the point of care.
- Primary CareWhen your clinic runs effectively, you have the freedom to provide the best care for your patients. HemoCue’s point-of-care testing systems enable quick and accurate results so that treatment decisions can be made with your patient still in the room.
Health Areas
- DiabetesReliable and accurate systems for screening, aiding in diagnosing and monitoring of diabetes are key for high quality patient care.
- InfectionsEffective point-of-care tools for infection detection giving you fast and accurate results, in combination with observations of a patient's symptoms, can support quick decision-making.
- AnemiaBy providing access to accurate screening tools, you can more easily detect those at risk. HemoCue’s point-of-care testing systems are portable and easy to use, even in remote settings.
Knowledge Center
- Knowledge Center
Our company
Contact
- Contact
- Technical support

HemoCue exhibits at SASOP Congress 2025

September 15, 2025 Exhibitions

Welcome to HemoCue at SASOP Congress 2025

HemoCue South Africa is proud to be part of the SASOP Congress 2025, hosted at the East London International Convention Centre under the theme “Re-imagining Mental Health Care Access.”
As part of our commitment to supporting psychiatric care, we’re showcasing the HemoCue WBC DIFF System, a reliable solution for compliant WBC and ANC monitoring in treatment-resistant schizophrenia (TRS) patients on clozapine.

If you’re interested in learning more or connecting with our team, please leave your details below. We look forward to continuing the conversation beyond the congress.